Kingdon Capital Management, L.L.C. Sol Gel Technologies Ltd. Transaction History
Kingdon Capital Management, L.L.C.
- $862 Million
- Q2 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 121,706 shares of SLGL stock, worth $79,108. This represents 0.01% of its overall portfolio holdings.
Number of Shares
121,706
Previous 481,749
74.74%
Holding current value
$79,108
Previous $472,000
77.12%
% of portfolio
0.01%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
7.34MCall Options Held
5.4KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.61 Million0.04% of portfolio
-
Armistice Capital, LLC New York, NY2.03MShares$1.32 Million0.02% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$797,9060.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$598,2160.02% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$148,9650.04% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $15M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...